Taxane Resistance in Prostate Cancer Mediated by AR-Independent GATA2 Regulation of IGF2

Cancer Cell

Volumn 27, Issue 2, 2015, Pages 158-159

  Plymate, StephenR ^a   Bhatt, Rupal S ^b   Balk, StevenP ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABIRATERONE; ANDROGEN RECEPTOR; DOCETAXEL; ENZALUTAMIDE; FIGITUMUMAB; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SOMATOMEDIN B; TAXANE DERIVATIVE; TRANSCRIPTION FACTOR GATA 2; GATA2 PROTEIN, HUMAN;

ANDROGEN DEPRIVATION THERAPY; CANCER RESISTANCE; CASTRATION RESISTANT PROSTATE CANCER; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; MALE; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;

ANIMALS; GATA2 TRANSCRIPTION FACTOR; HUMANS; MALE; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;

EID: 84922823519     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2015.01.008     Document Type: Short Survey

References (10)

1. Cheng H.H., Gulati R., Azad A., Nadal R., Twardowski P., Vaishampayan U.N., Agarwal N., Heath E.I., Pal S.K., Rehman H.T., et al. Prostate Cancer Prostatic Dis. 2015, Published online January 20, 2015. 10.1038/pcan.2014.53.
2. de Bono J.S., Piulats J.M., Pandha H.S., Petrylak D.P., Saad F., Aparicio L.M., Sandhu S.K., Fong P., Gillessen S., Hudes G.R., et al. Clin. Cancer Res. 2014, 20:1925-1934.
3. Dean J.P., Sprenger C.C., Wan J., Haugk K., Ellis W.J., Lin D.W., Corman J.M., Dalkin B.L., Mostaghel E., Nelson P.S., et al. J.Clin. Endocrinol. Metab. 2013, 98:E820-E828.
4. Domingo-Domenech J., Vidal S.J., Rodriguez-Bravo V., Castillo-Martin M., Quinn S.A., Rodriguez-Barrueco R., Bonal D.M., Charytonowicz E., Gladoun N., de la Iglesia-Vicente J., et al. Cancer Cell 2012, 22:373-388.
5. Friedbichler K., Hofmann M.H., Kroez M., Ostermann E., Lamche H.R., Koessl C., Borges E., Pollak M.N., Adolf G., Adam P.J. Mol. Cancer Ther. 2014, 13:399-409.
6. Heni M., Hennenlotter J., Scharpf M., Lutz S.Z., Schwentner C., Todenhöfer T., Schilling D., Kühs U., Gerber V., Machicao F., et al. PLoS ONE 2012, 7:e50953.
7. Vidal S.J., Rodriguez-Bravo V., Castillo-Martin M., Quinn S.A., Rodriguez-Barrueco V., Lujambio A., Williams E., Sun X., de la Iglesia-Vicente J., Lee A., et al. Cancer Cell 2015, 27:223-239. this issue.
8. Wang Q., Li W., Liu X.S., Carroll J.S., Jänne O.A., Keeton E.K., Chinnaiyan A.M., Pienta K.J., Brown M. Mol. Cell 2007, 27:380-392.
9. Wu J.D., Haugk K., Coleman I., Woodke L., Vessella R., Nelson P., Montgomery R.B., Ludwig D.L., Plymate S.R. Clin. Cancer Res. 2006, 12:6153-6160.
10. Wu D., Sunkel B., Chen Z., Liu X., Ye Z., Li Q., Grenade C., Ke J., Zhang C., Chen H., et al. Nucleic Acids Res. 2014, 42:3607-3622.